Top Markets
Coin of the day
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Peringkat dalam Saham #7327
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Harga Saham
$36.75
Terakhir disinkronkan: 2026-08-27
Kapitalisasi Pasar
$1.63B
Perubahan (1 hari)
-0.78%
Perubahan (1 tahun)
-
Negara
US
Perdagangan Avalyn Pharma Inc. Common Stock (AVLN)

Kategori

Riwayat hasil dividen untuk Avalyn Pharma Inc. Common Stock (AVLN)
Hasil dividen (TTM) dari Avalyn Pharma Inc. Common Stock (simbol saham: AVLN) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Avalyn Pharma Inc. Common Stock (AVLN) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH